Brilacidin First-in-Class Defensin-Mimetic Drug C
Post# of 72430
![](/assets/46931549/no_avatar_available_thumb.jpg)
First-in-Class Defensin-Mimetic Drug Candidate
Mechanism of Action, Pre/Clinical Data and Academic Literature Supporting the Development of Brilacidin as a Potential Novel Coronavirus (COVID-19) Treatment
April 20, 2020
https://static1.squarespace.com/static/571535....20.20.pdf
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)